Search

everythinglearnresearchcommunity

for

Search:↓

The package offers tools for exploring potential miRNA changes in female hair loss.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

Transferrin receptor 1 is essential for normal function in the intestines, pancreas, and skin.

Activin A and follistatin control when ear hair cells form in mice.

The document concludes that MGRN1 affects mouse fur color by interfering with a receptor's signaling, but its full role in the body is still unknown.

Laser-pretreated blood for hair loss treatment was more effective and increased stem cells.

Fermented Rhus Verniciflua Stokes Extract may help hair grow in cells and mice.

Ginsenoside Rg4 from ginseng may help hair growth by activating certain cell signals.

A soluble factor in developing mouse whisker pads boosts nerve growth factor mRNA production.

PRPF is a safer and more effective treatment for hair loss than PRP.

Understanding EGFR roles could lead to new hair loss treatments.

A new mRNA variant of the SCF gene in sheep skin produces a shorter, different protein.

Placental growth factor may help treat hair loss.

Kdm6b is crucial for skin cell differentiation.

The fuzzy gene is crucial for controlling hair growth cycles.

Using basic fibroblast growth factor with minoxidil improves hair growth and patient satisfaction more than using minoxidil alone.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

TGFBR1 slows down cell growth in fine-wool sheep hair follicles.

Mutations in the DSG4 gene cause fragile, sparse hair in humans, mice, and rats.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

LGR5 helps maintain corneal cell characteristics and prevents unwanted changes by controlling specific cell signaling pathways.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Wnt4 is essential for heart repair and could be a target for heart disease treatment.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

Some people have genetic mutations that make them resistant to vitamin D, leading to rickets even with enough vitamin D intake.

SMAD4 is crucial for muscle repair in young adults but not in aged mice.

Ectodysplasin inhibits Wnt signaling to help form hair follicles.

Gefitinib therapy can cause unusual hair growth on the nose.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.